SGLT2 INHIBITORS

Clinical trials for SGLT2 INHIBITORS explained in plain language.

Never miss a new study

Get alerted when new SGLT2 INHIBITORS trials appear

Sign up with your email to follow new studies for SGLT2 INHIBITORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1 Not yet finished but already full! 1

Diabetes pill may halt deadly liver scarring in hepatitis b

Disease control Ongoing

This study is testing whether empagliflozin, a medication for diabetes, can prevent or slow the progression of liver scarring (fibrosis and cirrhosis) in people with chronic hepatitis B. The 106 participants are already taking standard antiviral drugs but still have significant l…

Matched conditions: SGLT2 INHIBITORS

Phase: PHASE4 • Sponsor: The University of Hong Kong • Aim: Disease control

Last updated Apr 01, 2026 14:41 UTC

SGLT2 INHIBITORS

Get alerted when new SGLT2 INHIBITORS trials appear

Diabetes pill may halt deadly liver scarring in hepatitis b